Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis

Apoptosis

Volumn 16, Issue 11, 2011, Pages 1150-1164

  Qi, Ling ^a   Bellail, Anita C ^a   Rossi, Michael R ^a   Zhang, Zhaobin ^a   Pang, Hui ^b   Hunter, Stephen ^a   Cohen, Cynthia ^a   Moreno, Carlos S ^a   Olson, Jeffrey J ^a   Li, Shibo ^b   Hao, Chunhai ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer stem cells; Caspase 8; Glioblastoma; TRAIL

Indexed keywords

CASPASE 8; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CASPASE 8; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENETIC LOCI; GENETIC MARKERS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION, HETEROLOGOUS;

EID: 82955195440     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0645-6     Document Type: Article

References (42)

1. Bellail AC, Tse MC, Song JH et al (2010) DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med 14:1303-1317
2. Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8:782-798
3. Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009) TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4:34-41
4. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760 (Pubitemid 44949604)
5. Liu G, Yuan X, Zeng Z et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblas-toma. Mol Cancer 5:67
6. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193-206
7. Reynolds BA, Weiss S (1992) Generation of neurons and astro-cytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710
8. Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828 (Pubitemid 37187480)
9. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401 (Pubitemid 39551674)
10. Galli R, Binda E, Orfanelli U et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021 (Pubitemid 39331011)
11. Yuan X, Curtin J, Xiong Y et al (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400 (Pubitemid 40069671)
12. Lee J, Kotliarova S, Kotliarov Y et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403 (Pubitemid 43668737)
13. Bao S, Wu Q, Sathornsumetee S et al (2006) Stem cell-like gli-oma cells promote tumor angiogenesis through vascular endo-thelial growth factor. Cancer Res 66:7843-7848 (Pubitemid 44299144)
14. Li Z, Bao S, Wu Q et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501-513
15. Beier D, Hau P, Proescholdt M et al (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010-4015 (Pubitemid 46815044)
16. Laks DR, Masterman-Smith M, Visnyei K et al (2009) Neuro-sphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27:980-987
17. Kanamori M, Kawaguchi T, Nigro JM et al (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106:417-427 (Pubitemid 46354295)
18. Bar EE, Chaudhry A, Lin A et al (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524-2533 (Pubitemid 47582744)
19. Jiang H, Gomez-Manzano C, Aoki H et al (2007) Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99: 1410-1414 (Pubitemid 351767180)
20. Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meir EG, Hao C (2003) TRAIL triggers apoptosis in malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol 13:539-553 (Pubitemid 37420698)
21. Ishii N, Maier D, Merlo A et al (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469-479 (Pubitemid 29316287)
22. Hao C, Parney IF, Roa WH, Turner J, Petruk KC, Ramsay DA (2002) Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol (Berl) 103:171-178 (Pubitemid 36067496)
23. Hao C, Beguinot F, Condorelli G et al (2001) Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61:1162-1170 (Pubitemid 32174439)
24. Kischkel FC, Kioschis P, Weitz S, Poustka A, Lichter P, Krammer PH (1998) Assignment of CASP8 to human chromosome band 2q33→q34 and Casp8 to the murine syntenic region on chromosome 1B-proximal C by in situ hybridization. Cytogenet Cell Genet 82:95-96 (Pubitemid 28472786)
25. Ashkenazi A, Pai RC, Fong S et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162
26. Roth W, Isenmann S, Naumann U et al (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 265:479-483
27. Pollack IF, Erff M, Ashkenazi A (2001) Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res 7:1362-1369 (Pubitemid 32708693)
28. Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ (2001) Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 20:5789-5798 (Pubitemid 32937948)
29. Ichikawa K, Liu W, Zhao L et al (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7:954-960 (Pubitemid 32756434)
30. Xiao C, Yang BF, Asadi N, Beguinot F, Hao C (2002) Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem 277:25020-25025 (Pubitemid 34951805)
31. Bodmer JL, Holler N, Reynard S et al (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2:241-243
32. Scaffidi C, Medema JP, Krammer PH, Peter ME (1997) FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272:26953-26958 (Pubitemid 27452647)
33. Boatright KM, Renatus M, Scott FL et al (2003) A unified model for apical caspase activation. Mol Cell 11:529-541 (Pubitemid 36293843)
34. Chang DW, Xing Z, Capacio VL, Peter ME, Yang X (2003) Interdimer processing mechanism of procaspase-8 activation. EMBO J 22:4132-4142 (Pubitemid 37021742)
35. Donepudi M, Mac Sweeney A, Briand C, Grutter MG (2003) Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 11:543-549 (Pubitemid 36297058)
36. Li YC, Tzeng CC, Song JH et al (2006) Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res 12:2716-2729
37. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60:4315-4319 (Pubitemid 32103601)
38. Eggert A, Grotzer MA, Zuzak TJ et al (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61:1314-1319 (Pubitemid 34292549)
39. Kim HS, Lee JW, Soung YH et al (2003) Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125:708-715 (Pubitemid 37070689)
40. Soung YH, Lee JW, Kim SY et al (2005) CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 65:815-821
41. Panner A, James CD, Berger MS, Pieper RO (2005) mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 25:8809-8823 (Pubitemid 41429073)
42. Panner A, Murray JC, Berger MS, Pieper RO (2007) Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res 67:9482-9489 (Pubitemid 47535938)